tiprankstipranks
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market

Cipher Pharmaceuticals (CPH) Income Statement

Compare
77 Followers

Cipher Pharmaceuticals Income Statement

Last quarter (Q3 2024), Cipher Pharmaceuticals's total revenue was $10.37M, an increase of 70.90% from the same quarter last year. In Q3, Cipher Pharmaceuticals's net income was $283.00K. See Cipher Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 21.16M$ 20.68M$ 21.94M$ 21.61M$ 22.45M
Gross Profit
$ 17.09M$ 16.68M$ 18.26M$ 18.55M$ 19.55M
Operating Expenses
$ 5.56M$ 5.63M$ 6.45M$ 6.39M$ 8.04M
Depreciation and Amortization
$ 1.23M$ 989.00K$ 701.00K$ 1.21M$ 1.19M
EBITDA
$ 11.26M$ 11.95M$ 13.66M$ 13.40M$ 12.87M
Operating Income
$ 11.53M$ 11.09M$ 11.82M$ 12.20M$ 11.68M
Other Income/Expenses
$ 1.15M$ -560.00K$ -2.00M$ -5.63M$ -5.79M
Pretax Income
$ 12.68M$ 11.48M$ 11.06M$ 6.54M$ 5.71M
Net Income
$ 20.38M$ 26.64M$ 7.76M$ 4.55M$ 3.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.80$ 0.25$ 0.29$ 0.17$ 0.12
Diluted EPS
$ 0.80$ 0.25$ 0.29$ 0.17$ 0.12
Weighted Average Shares Outstanding
25.48M 107.49M 26.60M 27.03M 26.85M
Weighted Average Shares Outstanding (Diluted)
25.42M 107.49M 26.83M 27.37M 26.96M
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis